{"id":24536,"date":"2018-03-19T11:09:45","date_gmt":"2018-03-19T19:09:45","guid":{"rendered":"http:\/\/cannabiscultivatornews.com\/home\/index.php\/2018\/03\/19\/unit-of-big-pharmaceutical-firm-novartis-partners-with-medical-marijuana-producer-tilray\/"},"modified":"2018-03-20T01:01:07","modified_gmt":"2018-03-20T09:01:07","slug":"unit-of-big-pharmaceutical-firm-novartis-partners-with-medical-marijuana-producer-tilray","status":"publish","type":"post","link":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2018\/03\/19\/unit-of-big-pharmaceutical-firm-novartis-partners-with-medical-marijuana-producer-tilray\/","title":{"rendered":"Unit of big pharmaceutical firm Novartis partners with medical marijuana producer Tilray"},"content":{"rendered":"<\/p>\n<p>Toronto-based medical marijuana producer Tilray announced Monday it has formed a strategic partnership with Sandoz Canada, the first known affiliation between a marijuana producer and a major pharmaceutical company. Tilray signed a letter of intent with the Quebec-based affiliate of Sandoz International GmbH, an arm of global health care giant Novartis. The entry of Big [\u2026]<\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/mjbizdaily.com\/major-pharmaceutical-firm-novartis-partners-medical-marijuana-producer-tilray\/\">Unit of big pharmaceutical firm Novartis partners with medical marijuana producer Tilray<\/a> is a post from: <a href=\"http:\/\/mjbizdaily.com\">Marijuana Business Daily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs<\/a><\/p>\n<p>&#013;<br \/>\n&#013;<br \/>\nRead More: <a href=\"https:\/\/mjbizdaily.com\/major-pharmaceutical-firm-novartis-partners-medical-marijuana-producer-tilray\/\" target=\"_blank\">Unit of big pharmaceutical firm Novartis partners with medical marijuana producer Tilray<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Toronto-based medical marijuana producer Tilray announced Monday it has formed a strategic partnership with Sandoz Canada, the first known affiliation between a marijuana producer and a major pharmaceutical company. Tilray signed a letter of intent with the Quebec-based affiliate of Sandoz International GmbH, an arm of global health care giant<span class=\"more-link\"><a href=\"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2018\/03\/19\/unit-of-big-pharmaceutical-firm-novartis-partners-with-medical-marijuana-producer-tilray\/\">Continue Reading<\/a><\/span><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3702,682,3703,18,2786,3704,3705,1088],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/24536"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=24536"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/24536\/revisions"}],"predecessor-version":[{"id":24537,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/24536\/revisions\/24537"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=24536"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=24536"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=24536"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}